SlideShare une entreprise Scribd logo
1  sur  50
TOPIC PRESENTATION
CORONA VIRUS
MUKESH PANDIT
XI – D
S.D PUBLIC SCHOOL
VIRUSES : Vs BACTERIA Vs FUNGI
VIRUSES :-
• Viruses are known to infect unicellular
organisms such as Mycoplasma, bacteria,
algae and all other higher plants and animals.
• Virion is the complete virus particle. It
includes nucleocapsid plus a surrounding
envelope.
DNA Viruses : -
• All are ds except Parvovirus : ss { @ part – of – a – virus}
• All have liner genomes except Papilloma, Polyoma and
Hepadna : circular.
• All are icosahedral except Pox virus : complex.
• All replicate in the nucleus except Pox virus : carries
own DNA - dependent RNA polymerase. { @ out - of - the
– box}
RNA Viruses : -
• All are ss except Reovirus : ds { @ Repeato }
• Negative strand ( - ) ss RNA :
• Always : Arenavirus
• Bring : Bunyavirus
• Polymerase : Paramyxovirus
• Fail : Filovirus
• Replication : Rhabdovirus
RNA Viruses : -
• Positive strand ( + ) ssRNA : -
• Call : Calicivirus
• Henry : Hepevirus
• PiCo : Picornavirus and Coronavirus
• To : Togavirus
• Fly : Flavivirus
• Rightaway : Retrovirus
Viral envelopes : -
• Generally , enveloped viruses acquire their envelop
from plasma membrane when they exit from host
cell.
• However , exceptionally Hepesvirus acquire
envelopes from nuclear membrane.
• NAKED VIRUSES are :-
• DNA : PAPP ( Papilloma , Adeno , polyoma , parvo )
• RNA : CPR ( Calici , Picrona , Reo ; Hepe )
CORONA VIRUS : Phylogenetics
Order : Nidovirales
Family :- Arteriviridae
- Coronaviridae : Subfamilies : - Torovirinae
- Coronaviridae
Gener : - Alfacoronavirus
- Betacoronavirus } Can infect human
- Gammacoronavirus
- Bafanivirus
- Torovirus
Corona virus : Seven Species so far
 229E
 OC43
 NL63
 HKU1
 SARS – CoV
 MERS – CoV
 nCoV
} Common Cold
CRONA VIRUS
: -
Repliacotion
CORONA VIRUS : Reservoirs
Zoonoti Disease ( Animal's  Human)
SARS  2003  China ( Civat Cats)
MERS  2012  Saudi Arabia ( Camels)
Noval nCov  2019 December  Wuhan, Hubei
Province of China ( ? Animal )  Seafood and wild
Animal market.
CORONA
VIRUS : - nCoV
• Although, sea foods and wild animal's markets
were thought to be the epicenter of the outbreak.
• Now there is a school of thought
regarding Pangolins could have transmitted these
disease. Genetic analysis showed almost 99%
similarity of the viral genome in human to that of
the Pangolins.
• Pangolins are considere of medicinal value in
treatment of skin diseases, menstrul abhormalities
and joint diseases. The trading of these valuable
animal could subject to imprisonment for 10 years in
China.
CORONA VIRUS : Pathogenesis
Highly species – secific
Display tropis for epithelial cells. However , SARS had also predilection
for salivary glands is monkeys.
Virus can also be detected in Kidneys, live and small intestine and, and
in stool.
Corona virus are suspected of causing some gestroentritis in humans.
CORONA VIRUS : Clinical Features
Mostly : Common cold usually afelorille as caused by
rhinovirus.
SARS and MARS : Severe Respiratory illnesses
Diarrhea as caused by rotavirus
CORONA VIRUS
: - Immunity
• As with other respiratory virus, immunity
develops but is not absolute.
• Immunity against the surface projection
antigen is probably most important for
protection.
CORONA VIRUS : Lab Diagnosis
1. Antigen and nucleic acid detection.
 ELISA if high – quality antiserum is available
 Electron microscopy of stool specimen
 PCR assays
2. Isolation and Identification of virus.
 Difficult to culture in-vitro
 SARS was recovered from oropharyngeal specimens using vero monkey
Kidney cells.
3. Serology
 ELISA – Indirect IF
Visualization of 2019-nCoV with Transmission Electron
Microscopy.
CORONA VIRUS : Genomes
CORONA VIRUS :
Genomes
CORONA VIRUS :
Epidemiology
CORONA VIRUS :
Epidemiology
CORONA VIRUS : Epidemiology
CORONA VIRUS :
Epidemiology
CORONA
VIRUS :
Epidemiology
CORONA VIRUS : nCoV : Nepal : 3 cases
A 31yr. old student returned from Wuhan was found corona positive
when his throat swab was sent and examined in the who regional
headquarter, Hongkong.
Later a men and women were also suspected. However, 28yr. Old men
who had transit in china was positive for the corona virus.
48yr. Old women who went for an event was found negative for the virus.
CORONA VIRUS : nCoV : 1st case in US
• December 31st 2019 -----> Clusters of cases of pneumonia in Wuhan,
Hubei Province of -------> Huanan seafood wholesale market -------> On
Jan 7th Chinese authorities confirmed these cases were associated
with novel corona virus.
• First case reported in US was in 20th January 2020.
CORONA VIRUS : nCoV : 1st case in US
On January 19, 35-years-old man presented to an urgent care clinic in
Snohomish County, Washington with 4 day h/o cough and subjective
fever
He disclosed he has returned to Washington on January 15 after
traveling to visit family in Wuhan.
He said he had seen the health alert systems from CDC regarding
symptoms of the disease.
CORONA VIRUS : nCoV : 1st case in US
He has h/o hypertriglyceridemia. Otherwise healthy non-smoker.
Temp: 37.2 celcius
BP: 134/87 mmHg
Pulse: 110 bpm
RR: 16 bpm
Spo2 @ ambient air: 96%
CORONA VIRUS : nCoV : 1st case in US
A rapid nucleic acid amplification test (NAAT) for influenza A and B was
negative.
A nasopharyngeal swab specimen was obtained and sent for detection of viral
respiratory pathogens by NAAT; this was reported back within 48 hours as
negative for all pathogens tested, including influenza A and B, parainfluenza,
respiratory syncytial virus, rhinovirus, adenovirus, and four common
coronavirus strains known to cause illness in humans (HKU1, NL63, 229E, and
OC43).
CORONA VIRUS : nCoV : 1st case in US
Although the patient reported that he had not spent time at the Huanan
seafood market and reported no known contact with ill persons during his
travel to China, CDC staff concurred with the need to test the patient for 2019-
nCoV on the basis of current CDC “persons under investigation” case
definitions.
After specimen collection, the patient was discharged to home isolation with
active monitoring by the local health department.
CORONA VIRUS :
nCoV : 1st case in
US
CORONA VIRUS : nCoV : 1st case in US
On January 20, 2020, the CDC confirmed that the patient’s nasopharyngeal and
oropharyngeal swabs tested positive for 2019-nCoV by real-time reverse-
transcriptase–polymerase-chain-reaction (rRT-PCR) assay.
On admission, the patient reported persistent dry cough and a 2-day history of
nausea and vomiting; he reported that he had no shortness of breath or chest pain.
Vital signs were within normal ranges
CORONA VIRUS : nCoV : 1st case in US
After admission, the patient received supportive care, including 2 liters of normal saline and
ondansetron for nausea.
The patient continued to report a nonproductive cough and appeared fatigued.
On the afternoon of hospital day 2, the patient passed a loose bowel movement and reported
abdominal discomfort. A second episode of loose stool was reported overnight
A sample of this stool was collected for rRT-PCR testing, along with additional respiratory
specimens (nasopharyngeal and oropharyngeal) and serum.
The stool and both respiratory specimens later tested positive by rRT-PCR for 2019-nCoV,
whereas the serum remained negative.
CORONA VIRUS : nCoV : 1st case in US
Treatment during this time was largely supportive. For symptom
management, the patient received, as needed,
antipyretic therapy consisting of 650 mg of acetaminophen every 4 hours
and
600 mg of ibuprofen every 6 hours
600 mg of guaifenesin for his continued cough
approximately 6 liters of normal saline over the first 6 days of
hospitalization.
CORONA VIRUS :
nCoV : 1st case in US
CORONA VIRUS : nCoV :
1st case in US
CORONA VIRUS :
nCoV : 1st case in US
CORONA VIRUS : nCoV : 1st case in US
Laboratory results on hospital days 3 and 5 (illness days 7 and 9) reflected
leukopenia, mild thrombocytopenia, and elevated levels of creatine kinase.
In addition, there were alterations in hepatic function measures on day 5 of
hospitalization:
alkaline phosphatase (68 U per liter),
alanine aminotransferase (105 U per liter),
aspartate aminotransferase (77 U per liter),
lactate dehydrogenase (465 U per liter)
CORONA
VIRUS : nCoV
: 1st case in
US
CORONA VIRUS : nCoV : 1st case in US
Change in respiratory status was noticed starting on the evening of
hospital day 5, when the patient’s oxygen saturation values as
measured by pulse oximetry dropped to as low as 90% while he
was breathing ambient air
Given the changing clinical presentation and concern about
hospital-acquired pneumonia, treatment with vancomycin (a 1750-
mg loading dose followed by 1 g administered intravenously every
8 hours) and cefepime (administered intravenously every 8 hours)
was initiated.
CORONA VIRUS : nCoV : 1st case in US
CORONA VIRUS : nCoV : 1st case in US
Given the radiographic findings, the decision to
administer oxygen supplementation, the patient’s
ongoing fevers, the persistent positive 2019-nCoV RNA at
multiple sites, and published reports of the development
of severe pneumonia at a period consistent with the
development of radiographic pneumonia in this patient,
clinicians pursued compassionate use of an
investigational antiviral therapy
CORONA VIRUS : nCoV : 1st case in US
Treatment with intravenous remdesivir (a novel nucleotide
analogue prodrug in development) was initiated on the
evening of day 7, and no adverse events were observed in
association with the infusion.
Vancomycin was discontinued on the evening of day 7, and
cefepime was discontinued on the following day, after serial
negative procalcitonin levels and negative nasal PCR testing
for methicillin-resistant Staphylococcus aureus.
CORONA VIRUS : nCoV : 1st case in US
On hospital day 8 (illness day 12), the patient’s clinical
condition improved. Supplemental oxygen was discontinued,
and his oxygen saturation values improved to 94 to 96% while
he was breathing ambient air.
The previous bilateral lower-lobe rales were no longer present.
His appetite improved, and he was asymptomatic aside from
intermittent dry cough and rhinorrhea.
CORONA VIRUS : nCoV : 1st
case in US
• As of January 30, 2020, the
patient remains hospitalized.
He is afebrile, and all
symptoms have resolved with
the exception of his cough,
which is decreasing in severity.
• PRESENTED BY – MUKESH PANDIT
• CLASS --- XI – D
• SCHOOL – SD PUBLIC SCHOOL

Contenu connexe

Tendances

Tendances (20)

Corona virus disease 2019
Corona virus disease 2019Corona virus disease 2019
Corona virus disease 2019
 
COVID-19 (Coronavirus Disease 2019)
COVID-19 (Coronavirus Disease 2019)COVID-19 (Coronavirus Disease 2019)
COVID-19 (Coronavirus Disease 2019)
 
Covid 19 disease information ppt
Covid 19 disease information pptCovid 19 disease information ppt
Covid 19 disease information ppt
 
Covid 19 a short briefing
Covid 19 a short briefingCovid 19 a short briefing
Covid 19 a short briefing
 
2019 novel corona virus wuhan, china
2019 novel corona virus wuhan, china2019 novel corona virus wuhan, china
2019 novel corona virus wuhan, china
 
Corona virus
Corona virusCorona virus
Corona virus
 
Covid 19
Covid 19Covid 19
Covid 19
 
Covid 19 (corona virus)
Covid 19 (corona virus)Covid 19 (corona virus)
Covid 19 (corona virus)
 
Corona virus current scenario (theoretical outlook)
Corona virus current scenario (theoretical outlook)Corona virus current scenario (theoretical outlook)
Corona virus current scenario (theoretical outlook)
 
Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...
Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...
Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...
 
An overview on coronavirus (COVID-19)
An overview on coronavirus (COVID-19)An overview on coronavirus (COVID-19)
An overview on coronavirus (COVID-19)
 
Ppt on corona
Ppt on coronaPpt on corona
Ppt on corona
 
Coronavirus epidemiology, COVID, COVID & intestinal involvement, Hypoxia in C...
Coronavirus epidemiology, COVID, COVID & intestinal involvement, Hypoxia in C...Coronavirus epidemiology, COVID, COVID & intestinal involvement, Hypoxia in C...
Coronavirus epidemiology, COVID, COVID & intestinal involvement, Hypoxia in C...
 
Covid19 by likhit
Covid19  by likhitCovid19  by likhit
Covid19 by likhit
 
Covid 19
Covid 19Covid 19
Covid 19
 
Coronaviruses & COVID 19 - Its Morphology, Role, Mechanism of Action, and Tre...
Coronaviruses & COVID 19 - Its Morphology, Role, Mechanism of Action, and Tre...Coronaviruses & COVID 19 - Its Morphology, Role, Mechanism of Action, and Tre...
Coronaviruses & COVID 19 - Its Morphology, Role, Mechanism of Action, and Tre...
 
Corona Virus Awareness by, Er. Swapnil V. Kaware
Corona Virus Awareness by, Er. Swapnil V. KawareCorona Virus Awareness by, Er. Swapnil V. Kaware
Corona Virus Awareness by, Er. Swapnil V. Kaware
 
Coronavirus presentation
Coronavirus presentationCoronavirus presentation
Coronavirus presentation
 
Coronavirus disease (covid 19)
Coronavirus disease (covid 19)Coronavirus disease (covid 19)
Coronavirus disease (covid 19)
 
Covid 19
Covid 19Covid 19
Covid 19
 

Similaire à Corona virus ppt

Clinical features of patients infected with 2019 novel copy
Clinical features of patients infected with 2019 novel   copyClinical features of patients infected with 2019 novel   copy
Clinical features of patients infected with 2019 novel copy
MadhumitaSingh23
 

Similaire à Corona virus ppt (20)

Covid 19 aka mers cov2 update and perinatal covid
Covid 19 aka mers cov2 update and perinatal covidCovid 19 aka mers cov2 update and perinatal covid
Covid 19 aka mers cov2 update and perinatal covid
 
Deadly Coronavirus pathogenesis and management
Deadly Coronavirus pathogenesis and managementDeadly Coronavirus pathogenesis and management
Deadly Coronavirus pathogenesis and management
 
Novel coronavirus (covid-19) A Pandemic disease
Novel coronavirus (covid-19) A Pandemic disease Novel coronavirus (covid-19) A Pandemic disease
Novel coronavirus (covid-19) A Pandemic disease
 
Lab test for covid 19 explained!
Lab test for covid 19 explained!Lab test for covid 19 explained!
Lab test for covid 19 explained!
 
Clinical presentation of Covid 19
Clinical presentation of Covid 19Clinical presentation of Covid 19
Clinical presentation of Covid 19
 
Novel Coronavirus spotlight
Novel Coronavirus spotlightNovel Coronavirus spotlight
Novel Coronavirus spotlight
 
Respiratory.ppt
Respiratory.pptRespiratory.ppt
Respiratory.ppt
 
Coronaviridae.pdf
Coronaviridae.pdfCoronaviridae.pdf
Coronaviridae.pdf
 
Corona virus brief introduction
Corona virus brief introduction Corona virus brief introduction
Corona virus brief introduction
 
Novel corona virus (n cov 2019)
Novel corona virus (n cov  2019)Novel corona virus (n cov  2019)
Novel corona virus (n cov 2019)
 
Mers cov
Mers covMers cov
Mers cov
 
CoronaVirus (short Version)
CoronaVirus (short Version)CoronaVirus (short Version)
CoronaVirus (short Version)
 
Covid 19 convalescent plasma therapy
Covid 19 convalescent plasma therapyCovid 19 convalescent plasma therapy
Covid 19 convalescent plasma therapy
 
SARS clinical features treatment and complications
SARS clinical features treatment and complicationsSARS clinical features treatment and complications
SARS clinical features treatment and complications
 
COVID 19-De pope.pdf
COVID 19-De pope.pdfCOVID 19-De pope.pdf
COVID 19-De pope.pdf
 
Corona virus 2019-nCoV
Corona virus 2019-nCoVCorona virus 2019-nCoV
Corona virus 2019-nCoV
 
Coronavirus(covid 19)
Coronavirus(covid 19)Coronavirus(covid 19)
Coronavirus(covid 19)
 
Corona Virus and Reinfection(Second Time Infection)
Corona Virus  and Reinfection(Second Time Infection)Corona Virus  and Reinfection(Second Time Infection)
Corona Virus and Reinfection(Second Time Infection)
 
Clinical features of patients infected with 2019 novel copy
Clinical features of patients infected with 2019 novel   copyClinical features of patients infected with 2019 novel   copy
Clinical features of patients infected with 2019 novel copy
 
Review Article on Norovirus
Review Article on NorovirusReview Article on Norovirus
Review Article on Norovirus
 

Dernier

Dernier (20)

HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptx
 

Corona virus ppt

  • 1. TOPIC PRESENTATION CORONA VIRUS MUKESH PANDIT XI – D S.D PUBLIC SCHOOL
  • 2. VIRUSES : Vs BACTERIA Vs FUNGI
  • 3. VIRUSES :- • Viruses are known to infect unicellular organisms such as Mycoplasma, bacteria, algae and all other higher plants and animals. • Virion is the complete virus particle. It includes nucleocapsid plus a surrounding envelope.
  • 4. DNA Viruses : - • All are ds except Parvovirus : ss { @ part – of – a – virus} • All have liner genomes except Papilloma, Polyoma and Hepadna : circular. • All are icosahedral except Pox virus : complex. • All replicate in the nucleus except Pox virus : carries own DNA - dependent RNA polymerase. { @ out - of - the – box}
  • 5. RNA Viruses : - • All are ss except Reovirus : ds { @ Repeato } • Negative strand ( - ) ss RNA : • Always : Arenavirus • Bring : Bunyavirus • Polymerase : Paramyxovirus • Fail : Filovirus • Replication : Rhabdovirus
  • 6. RNA Viruses : - • Positive strand ( + ) ssRNA : - • Call : Calicivirus • Henry : Hepevirus • PiCo : Picornavirus and Coronavirus • To : Togavirus • Fly : Flavivirus • Rightaway : Retrovirus
  • 7. Viral envelopes : - • Generally , enveloped viruses acquire their envelop from plasma membrane when they exit from host cell. • However , exceptionally Hepesvirus acquire envelopes from nuclear membrane. • NAKED VIRUSES are :- • DNA : PAPP ( Papilloma , Adeno , polyoma , parvo ) • RNA : CPR ( Calici , Picrona , Reo ; Hepe )
  • 8.
  • 9. CORONA VIRUS : Phylogenetics Order : Nidovirales Family :- Arteriviridae - Coronaviridae : Subfamilies : - Torovirinae - Coronaviridae Gener : - Alfacoronavirus - Betacoronavirus } Can infect human - Gammacoronavirus - Bafanivirus - Torovirus
  • 10.
  • 11. Corona virus : Seven Species so far  229E  OC43  NL63  HKU1  SARS – CoV  MERS – CoV  nCoV } Common Cold
  • 13. CORONA VIRUS : Reservoirs Zoonoti Disease ( Animal's  Human) SARS  2003  China ( Civat Cats) MERS  2012  Saudi Arabia ( Camels) Noval nCov  2019 December  Wuhan, Hubei Province of China ( ? Animal )  Seafood and wild Animal market.
  • 14. CORONA VIRUS : - nCoV • Although, sea foods and wild animal's markets were thought to be the epicenter of the outbreak. • Now there is a school of thought regarding Pangolins could have transmitted these disease. Genetic analysis showed almost 99% similarity of the viral genome in human to that of the Pangolins. • Pangolins are considere of medicinal value in treatment of skin diseases, menstrul abhormalities and joint diseases. The trading of these valuable animal could subject to imprisonment for 10 years in China.
  • 15. CORONA VIRUS : Pathogenesis Highly species – secific Display tropis for epithelial cells. However , SARS had also predilection for salivary glands is monkeys. Virus can also be detected in Kidneys, live and small intestine and, and in stool. Corona virus are suspected of causing some gestroentritis in humans.
  • 16. CORONA VIRUS : Clinical Features Mostly : Common cold usually afelorille as caused by rhinovirus. SARS and MARS : Severe Respiratory illnesses Diarrhea as caused by rotavirus
  • 17. CORONA VIRUS : - Immunity • As with other respiratory virus, immunity develops but is not absolute. • Immunity against the surface projection antigen is probably most important for protection.
  • 18. CORONA VIRUS : Lab Diagnosis 1. Antigen and nucleic acid detection.  ELISA if high – quality antiserum is available  Electron microscopy of stool specimen  PCR assays 2. Isolation and Identification of virus.  Difficult to culture in-vitro  SARS was recovered from oropharyngeal specimens using vero monkey Kidney cells. 3. Serology  ELISA – Indirect IF
  • 19. Visualization of 2019-nCoV with Transmission Electron Microscopy.
  • 20. CORONA VIRUS : Genomes
  • 24. CORONA VIRUS : Epidemiology
  • 27. CORONA VIRUS : nCoV : Nepal : 3 cases A 31yr. old student returned from Wuhan was found corona positive when his throat swab was sent and examined in the who regional headquarter, Hongkong. Later a men and women were also suspected. However, 28yr. Old men who had transit in china was positive for the corona virus. 48yr. Old women who went for an event was found negative for the virus.
  • 28.
  • 29. CORONA VIRUS : nCoV : 1st case in US • December 31st 2019 -----> Clusters of cases of pneumonia in Wuhan, Hubei Province of -------> Huanan seafood wholesale market -------> On Jan 7th Chinese authorities confirmed these cases were associated with novel corona virus. • First case reported in US was in 20th January 2020.
  • 30. CORONA VIRUS : nCoV : 1st case in US On January 19, 35-years-old man presented to an urgent care clinic in Snohomish County, Washington with 4 day h/o cough and subjective fever He disclosed he has returned to Washington on January 15 after traveling to visit family in Wuhan. He said he had seen the health alert systems from CDC regarding symptoms of the disease.
  • 31. CORONA VIRUS : nCoV : 1st case in US He has h/o hypertriglyceridemia. Otherwise healthy non-smoker. Temp: 37.2 celcius BP: 134/87 mmHg Pulse: 110 bpm RR: 16 bpm Spo2 @ ambient air: 96%
  • 32. CORONA VIRUS : nCoV : 1st case in US A rapid nucleic acid amplification test (NAAT) for influenza A and B was negative. A nasopharyngeal swab specimen was obtained and sent for detection of viral respiratory pathogens by NAAT; this was reported back within 48 hours as negative for all pathogens tested, including influenza A and B, parainfluenza, respiratory syncytial virus, rhinovirus, adenovirus, and four common coronavirus strains known to cause illness in humans (HKU1, NL63, 229E, and OC43).
  • 33. CORONA VIRUS : nCoV : 1st case in US Although the patient reported that he had not spent time at the Huanan seafood market and reported no known contact with ill persons during his travel to China, CDC staff concurred with the need to test the patient for 2019- nCoV on the basis of current CDC “persons under investigation” case definitions. After specimen collection, the patient was discharged to home isolation with active monitoring by the local health department.
  • 34. CORONA VIRUS : nCoV : 1st case in US
  • 35. CORONA VIRUS : nCoV : 1st case in US On January 20, 2020, the CDC confirmed that the patient’s nasopharyngeal and oropharyngeal swabs tested positive for 2019-nCoV by real-time reverse- transcriptase–polymerase-chain-reaction (rRT-PCR) assay. On admission, the patient reported persistent dry cough and a 2-day history of nausea and vomiting; he reported that he had no shortness of breath or chest pain. Vital signs were within normal ranges
  • 36. CORONA VIRUS : nCoV : 1st case in US After admission, the patient received supportive care, including 2 liters of normal saline and ondansetron for nausea. The patient continued to report a nonproductive cough and appeared fatigued. On the afternoon of hospital day 2, the patient passed a loose bowel movement and reported abdominal discomfort. A second episode of loose stool was reported overnight A sample of this stool was collected for rRT-PCR testing, along with additional respiratory specimens (nasopharyngeal and oropharyngeal) and serum. The stool and both respiratory specimens later tested positive by rRT-PCR for 2019-nCoV, whereas the serum remained negative.
  • 37. CORONA VIRUS : nCoV : 1st case in US Treatment during this time was largely supportive. For symptom management, the patient received, as needed, antipyretic therapy consisting of 650 mg of acetaminophen every 4 hours and 600 mg of ibuprofen every 6 hours 600 mg of guaifenesin for his continued cough approximately 6 liters of normal saline over the first 6 days of hospitalization.
  • 38. CORONA VIRUS : nCoV : 1st case in US
  • 39. CORONA VIRUS : nCoV : 1st case in US
  • 40. CORONA VIRUS : nCoV : 1st case in US
  • 41. CORONA VIRUS : nCoV : 1st case in US Laboratory results on hospital days 3 and 5 (illness days 7 and 9) reflected leukopenia, mild thrombocytopenia, and elevated levels of creatine kinase. In addition, there were alterations in hepatic function measures on day 5 of hospitalization: alkaline phosphatase (68 U per liter), alanine aminotransferase (105 U per liter), aspartate aminotransferase (77 U per liter), lactate dehydrogenase (465 U per liter)
  • 42. CORONA VIRUS : nCoV : 1st case in US
  • 43. CORONA VIRUS : nCoV : 1st case in US Change in respiratory status was noticed starting on the evening of hospital day 5, when the patient’s oxygen saturation values as measured by pulse oximetry dropped to as low as 90% while he was breathing ambient air Given the changing clinical presentation and concern about hospital-acquired pneumonia, treatment with vancomycin (a 1750- mg loading dose followed by 1 g administered intravenously every 8 hours) and cefepime (administered intravenously every 8 hours) was initiated.
  • 44. CORONA VIRUS : nCoV : 1st case in US
  • 45. CORONA VIRUS : nCoV : 1st case in US Given the radiographic findings, the decision to administer oxygen supplementation, the patient’s ongoing fevers, the persistent positive 2019-nCoV RNA at multiple sites, and published reports of the development of severe pneumonia at a period consistent with the development of radiographic pneumonia in this patient, clinicians pursued compassionate use of an investigational antiviral therapy
  • 46. CORONA VIRUS : nCoV : 1st case in US Treatment with intravenous remdesivir (a novel nucleotide analogue prodrug in development) was initiated on the evening of day 7, and no adverse events were observed in association with the infusion. Vancomycin was discontinued on the evening of day 7, and cefepime was discontinued on the following day, after serial negative procalcitonin levels and negative nasal PCR testing for methicillin-resistant Staphylococcus aureus.
  • 47. CORONA VIRUS : nCoV : 1st case in US On hospital day 8 (illness day 12), the patient’s clinical condition improved. Supplemental oxygen was discontinued, and his oxygen saturation values improved to 94 to 96% while he was breathing ambient air. The previous bilateral lower-lobe rales were no longer present. His appetite improved, and he was asymptomatic aside from intermittent dry cough and rhinorrhea.
  • 48. CORONA VIRUS : nCoV : 1st case in US • As of January 30, 2020, the patient remains hospitalized. He is afebrile, and all symptoms have resolved with the exception of his cough, which is decreasing in severity.
  • 49.
  • 50. • PRESENTED BY – MUKESH PANDIT • CLASS --- XI – D • SCHOOL – SD PUBLIC SCHOOL